Polar Asset Management Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-19,869
| Closed | -$7.12M | – | 804 |
|
|
2023
Q3 | $7.12M | Sell |
19,869
-52,800
| -73% | -$20.4M | 0.16% | 176 |
|
|
2023
Q2 | $27.6M | Sell |
72,669
-8,172
| -10% | -$3.33M | 0.5% | 37 |
|
|
2023
Q1 | $38.7M | Sell |
80,841
-22,659
| -22% | -$10.6M | 0.59% | 19 |
|
|
2022
Q4 | $43.5M | Buy |
103,500
+21,000
| +25% | +$8.48M | 0.53% | 19 |
|
|
2022
Q3 | $34.4M | Buy |
82,500
+15,000
| +22% | +$7.48M | 0.41% | 27 |
|
|
2022
Q2 | $33.4M | Buy |
67,500
+5,600
| +9% | +$2.92M | 0.39% | 34 |
|
|
2022
Q1 | $34.9M | Buy |
+61,900
| New | +$37.3M | 0.37% | 36 |
|
|
2020
Q3 | – | Sell |
-35,570
| Closed | -$16.1M | – | 594 |
|
|
2020
Q2 | $16.1M | Sell |
35,570
-75,695
| -68% | -$33.4M | 0.27% | 102 |
|
|
2020
Q1 | $39M | Buy |
111,265
+15,600
| +16% | +$5.74M | 0.79% | 16 |
|
|
2019
Q4 | $35.4M | Sell |
95,665
-39,300
| -29% | -$13.9M | 0.69% | 24 |
|
|
2019
Q3 | $44.9M | Sell |
134,965
-39,035
| -22% | -$12.7M | 0.8% | 18 |
|
|
2019
Q2 | $54.4M | Buy |
174,000
+28,500
| +20% | +$8.53M | 1.01% | 7 |
|
|
2019
Q1 | $44.5M | Buy |
145,500
+73,100
| +101% | +$19.7M | 0.98% | 9 |
|
|
2018
Q4 | $16.8M | Sell |
72,400
-8,500
| -11% | -$2.28M | 0.33% | 61 |
|
|
2018
Q3 | $25.3M | Sell |
80,900
-38,900
| -32% | -$12.1M | 0.49% | 37 |
|
|
2018
Q2 | $34.6M | Sell |
119,800
-32,378
| -21% | -$8.94M | 0.61% | 26 |
|
|
2018
Q1 | $38.1M | Sell |
152,178
-12,612
| -8% | -$3.21M | 0.63% | 15 |
|
|
2017
Q4 | $39.3M | Buy |
164,790
+67,595
| +70% | +$16.4M | 0.62% | 24 |
|
|
2017
Q3 | $21.6M | Buy |
97,195
+39,300
| +68% | +$8.84M | 0.43% | 49 |
|
|
2017
Q2 | $13.1M | Sell |
57,895
-8,300
| -13% | -$1.81M | 0.31% | 81 |
|
|
2017
Q1 | $13.2M | Sell |
66,195
-70,469
| -52% | -$13.6M | 0.34% | 65 |
|
|
2016
Q4 | $24.9M | Sell |
136,664
-51,914
| -28% | -$8.85M | 0.68% | 18 |
|
|
2016
Q3 | $30.9M | Buy |
188,578
+59,717
| +46% | +$9.06M | 0.96% | 17 |
|
|
2016
Q2 | $18.4M | Buy |
128,861
+3,422
| +3% | +$488K | 0.75% | 21 |
|
|
2016
Q1 | $17.1M | Sell |
125,439
-9,700
| -7% | -$1.27M | 0.73% | 18 |
|
|
2015
Q4 | $18.7M | Sell |
135,139
-11,861
| -8% | -$1.64M | 0.98% | 16 |
|
|
2015
Q3 | $19.7M | Buy |
147,000
+1,000
| +0.7% | +$144K | 1.19% | 13 |
|
|
2015
Q2 | $22M | Hold |
146,000
| – | – | 0.96% | 24 |
|
|
2015
Q1 | $19.7M | Sell |
146,000
-51,800
| -26% | -$6.42M | 1.08% | 15 |
|
|
2014
Q4 | $23.8M | Buy |
197,800
+18,686
| +10% | +$2.15M | 1.27% | 11 |
|
|
2014
Q3 | $20.3M | Hold |
179,114
| – | – | 1.05% | 20 |
|
|
2014
Q2 | $21.4M | Buy |
179,114
+15,000
| +9% | +$1.83M | 1.14% | 18 |
|
|
2014
Q1 | $21M | Buy |
164,114
+18,776
| +13% | +$2.41M | 0.93% | 20 |
|
|
2013
Q4 | $18M | Buy |
145,338
+18,336
| +14% | +$2.23M | 0.76% | 26 |
|
|
2013
Q3 | $14.9M | Buy |
127,002
+17,298
| +16% | +$2.04M | 0.63% | 39 |
|
|
2013
Q2 | $12.3M | Buy |
+109,704
| New | +$12.9M | 0.65% | 48 |
|
Other funds holding BIO
VAM
Polar Asset Management Partners's BIO Position: Q4 2023 in Review
Polar Asset Management Partners sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2023, closing a stake of 19,869 shares — an estimated $7.12M sold.
Polar Asset Management Partners first reported a position in BIO in Q2 2013 and held it in 36 quarters. The position peaked at $54.4M in Q2 2019. 484 funds tracked by Wall St. Rank hold BIO as of Q4 2023.
- Polar Asset Management Partners reported no remaining Bio-Rad Laboratories Class A position as of Q4 2023 after selling out during the quarter.
- Polar Asset Management Partners sold 19,869 Bio-Rad Laboratories Class A shares in Q4 2023, an estimated $7.12M.
- Polar Asset Management Partners first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 36 quarters.
- Polar Asset Management Partners's Bio-Rad Laboratories Class A position peaked at $54.4M in Q2 2019.
- 484 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2023.
Based on Polar Asset Management Partners's 13F filing for Q4 2023, filed 14 Feb 2024.